by European Alliance | May 23, 2022 | News
The European Alliance for Responsible R&D and Affordable Medicines welcomed the opportunity to provide feedback within this European Commission’s consultation on Intellectual property: revised framework for compulsory licensing of patents. Compulsory...
by European Alliance | Apr 7, 2022 | News
The Members of the European Alliance for Responsible R&D and Affordable Medicines have published a note today outlining key recommendations to prevent and mitigate shortages of medicines in the upcoming revision of the pharmaceutical legislation. The note...
by European Alliance | Mar 14, 2022 | News
The European Alliance for Responsible R&D and Affordable Medicines calls for all parties to protect the health and welfare and guarantee access to medical tools and healthcare for all people affected by the ongoing war in Ukraine Members of the Alliance are deeply...
by European Alliance | Jan 13, 2022 | News
On Tuesday 18 January 2022 (14:00-15:15), the Alliance co-hosted the second event of the Zooming in on Solution to the Affordability of Medicines webinar series along with Global Health Advocates (GHA) and the European Public Health Alliance (EPHA). Speakers and...
by European Alliance | Dec 21, 2021 | News
Brussels, 21 December 2021 Members of the Alliance have published a note today outlining key recommendations of civil society organisations for the new EU pharmaceutical strategy. A key pillar for this new strategy is the balance between providing innovation...
by European Alliance | Nov 15, 2021 | News
On Wednesday 17 November (9:30-11:30 am), the Alliance organized the regional dialogue for EU activists working on overcoming patent and other intellectual property barriers to access to health technologies. The dialogue provided a place for EU activists to reflect on...
